NCT06784232

Brief Summary

The modified periosteal inhibition technique has been proposed as an alternative to limit crestal resorption following tooth extraction in sockets with a residual vestibular thickness of \<1 mm. This technique aims to prevent osteolytic activity on the external surface of a post-extraction socket by applying a 0.5 mm-thick soft cortical plate of porcine origin, secured with fibrin glue. By avoiding the placement of bone graft material inside the socket, the technique seeks to effectively counteract bone remodeling, achieving minimal reduction in the size of the alveolar crest. The aim is to evaluate the effectiveness of the modified periosteal inhibition technique in preserving the dimensions of the alveolar ridge after tooth extraction, by comparing it with the Biologically-oriented Alveolar Ridge Preservation technique.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 14, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

1.1 years

First QC Date

January 14, 2025

Last Update Submit

January 17, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • ridge width reduction

    optical scanning comparison measured in millimetres at the mid-buccal and mid-palatal aspect of the socket

    26 weeks after tooth extraction and preservation tecnhique

  • ridge height reduction

    optical scanning comparison measured in millimetres at the mid-buccal, mid-palatal, mesial and distal aspect of the socket

    26 weeks after tooth extraction and preservation tecnhique

Secondary Outcomes (3)

  • histologic and histomorphometric analysis of new bone formation

    26 weeks after tooth extraction and preservation tecnhique

  • histologic and histomorphometric analysis of residual graft particles

    26 weeks after tooth extraction and preservation tecnhique

  • histologic and histomorphometric analysis of marrow spaces

    26 weeks after tooth extraction and preservation tecnhique

Study Arms (2)

BARP

collagen-bonegraft-collagen

Procedure: BARP

Modified Periosteal Inhibition Technique

cortical lamina, human fibrin glue and collagen

Procedure: Modified Periosteal Inhibition Technique

Interventions

BARPPROCEDURE

deep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer

BARP

Cortical lamina stabilized with human fibrin glue to preserve the buccal wall of the socket. The socket was then filled with collagen.

Modified Periosteal Inhibition Technique

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be conducted in an outpatient hospital setting.

You may qualify if:

  • Age between 18 and 80 years;
  • Single-rooted tooth with indication for extraction with sockets having a residual thickness of \<1 mm in the first 3 mm of the buccal residual crest presenting adjacent teeth;
  • American Society of Anesthesiologists 3;
  • Periodontal health or stability;
  • Signature of informed consent.

You may not qualify if:

  • Presence of periapical cystic lesions at the intervention sites;
  • Loss of bone tissue extending to the apical third on radiographic examination;
  • Extraction of adjacent teeth within a period ranging from 6 months prior to 6 months after the extraction;
  • Lack of one or more walls of the post-extraction socket;
  • Presence of general contraindications for oral surgery;
  • Presence of inflammatory and autoimmune diseases;
  • Uncontrolled diabetes (HbA1c 7%);
  • History of tumors requiring chemotherapy or radiotherapy in the last 5 years;
  • Previous therapy with bisphosphonates or high-dose corticosteroid therapy;
  • Smoking (10 cigarettes/day);
  • Allergy to bovine collagen;
  • Pregnancy or breastfeeding;
  • Lack of compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Trieste

Trieste, TS, 34127, Italy

Location

Biospecimen

Retention: SAMPLES WITH DNA

alveolar bone specimens withdrawn with trephine bur

MeSH Terms

Conditions

Alveolar Bone Loss

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2025

First Posted

January 20, 2025

Study Start

December 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 22, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations